TABLE 6.
Variable |
Pre-menopause |
Post-menopause |
||
DD (P-value) | DI/II (P-value) | DD (P-value) | DI/II (P-value) | |
NO | 0.032 | 0.301 | 0.614 | 0.442 |
ET-1 | 0.017 | 0.439 | 0.010 | 0.308 |
Ang II | 0.002 | 0.026 | 0.759 | 0.647 |
Multivariate regression analysis was used to evaluate the effects of ERFs on FMD. DD, homozygous deletion; DI/II, I allele carriers. NO, nitric oxide; ET-1, endothelin-1; Ang II, angiotensin II.